Posts filed under: Soft Tissue Reinforcement & Regeneration

TELA Bio’s OviTex Reinforced BioScaffold (RBS) products are a distinct class of surgical implants that integrate biologic and synthetic materials in a unique embroidered construction that allows free movement of fluid and cells through the construct....
Continue Reading →
Breast Reconstruction Awareness Day is a collaborative effort between the American Society of Plastic Surgeons (ASPS), The Plastic Surgery Foundation (The PSF), plastic surgeons specializing in breast surgery, nurse navigators, corporate partners, breast cancer support groups and organizations....
Continue Reading →
Demographic of those over the age of 65 is increasing in the U.S., which leads to a rise in the amount of people experiencing medical complications involving soft tissue reinforcement and regeneration...
Continue Reading →
An enhanced recovery protocol was associated with improved patient satisfaction and length of hospital stay among women undergoing alloplastic breast reconstruction. In the postmastectomy radiation setting, immediate autologous breast reconstruction yielded similar complication and satisfaction rates as delayed reconstruction....
Continue Reading →
In anticipation of questions related to the Zika virus, MiMedx is reconfirming the rigorous product safety methods and practices followed by the Company in the processing of its amniotic allografts as well as restating its precise standards for screening of...
Continue Reading →
Johnson & Johnson subsidiary Ethicon last month recalled 1 of its surgical mesh products after studies showed higher revision rates after a type of minimally invasive hernia repair using its Physiomesh flexible composite mesh....
Continue Reading →
The market for hernia repair has grown due to the general increase in hernia incidence in the United States. The U.S. market for soft tissue reinforcement and regeneration is expected to grow by nearly 8% by 2021....
Continue Reading →
The use of contralateral prophylactic mastectomy (CPM), the surgical removal of a breast unaffected by cancer as part of the course of treatment for breast cancer, has more than tripled from 2002 to 2012 despite evidence suggesting no survival benefit...
Continue Reading →
The FDA has approved the use of Integra Omnigraft Dermal Regeneration Matrix (Omnigraft) to treat diabetic foot ulcers that last for longer than six weeks and do not involve exposure of the joint capsule, tendon or bone, when used in...
Continue Reading →
Breast reconstruction is a missed opportunity for many women who undergo mastectomies, said Dr. Richard Cashio, a plastic surgeon at Florida Hospital Flagler in Palm Coast. Cashio supports a new education program by the federal government to let women know...
Continue Reading →

Thank you!

CLOSE

Login

Sign Up

Already have an account? Sign in

×